The Mounjaro Jab Price Increase Explained — and What Comes Next

The myth: the price hike means Mounjaro is no longer worth it for private patients

The biggest misconception circulating since September 2025 is that the price increase makes private Mounjaro unaffordable or unjustifiable. That's worth examining carefully. If you want a detailed breakdown of exactly what changed and when, our guide to the Mounjaro price increase covers the timeline and figures in full. That is a significant uplift, and legitimate providers passed it on. But the medicine itself, its clinical profile, and the trial evidence didn't change. What changed is that the gap between regulated, clinically supervised supply and unverified sellers selling pens for suspiciously little has become even more visible.

Private Mounjaro prices since September 2025 typically range roughly £149–£375 per month depending on the dose and provider. Whether that's within your budget is a personal financial question. Whether it's clinically appropriate for you is a separate one that only a prescriber can answer. Those two questions often get tangled up, and this page tries to untangle them. For a fuller look at where current market pricing sits across the dose range, our Mounjaro price guide covers the detail.

Mounjaro is a prescription-only medicine. Under UK law, a licensed prescriber must assess your suitability before it can be dispensed. That assessment isn't a formality, it's a clinical safeguard. The price of that safeguard, built into a legitimate private service, is part of what you're paying for.

What headline prices often leave out

A number quoted on a provider's website is rarely the full cost of treatment. Some services charge separately for the initial consultation. Some add a prescription fee on top. Delivery, which can mean cold-chain courier handling for an injectable medicine, sometimes appears as a line item at checkout. Aftercare (being able to contact a clinician if you have a reaction, or to discuss a dose change) may be billed as an add-on or simply absent.

This matters more now that prices are higher. When the market was cheaper, absorbing a surprise £20 delivery fee was irritating but manageable. When you're already paying more per pen, the total cost of a poorly-itemised service can end up well above what the headline suggested. The reasons behind the Mounjaro price increase are worth understanding so you can evaluate any provider's pricing honestly.

The questions worth asking any service: is the consultation free or charged? Is the prescription included? Is delivery included at every order, or only the first? Is clinical re-review built in before repeats, or do you pay again? These are not small print details, they are the actual cost of treatment.

How nume approaches pricing after the increase

A real clinician, not an algorithm, reads your consultation answers the same day. That's a named GPhC-registered prescriber reviewing your information before anything is dispensed. The price we charge includes the consultation, the prescription, the medicine, and free next-working-day delivery through DPD. Aftercare is available seven days a week. There are no bolt-on fees and no auto-renewals, every repeat is clinically re-reviewed from scratch.

We are not the cheapest option in the market. That is a deliberate position. Cheapest isn't a race we entered, because for a prescription medicine the incentives that produce the lowest price tend to be the ones that cut clinical corners. Our approach to clinical governance reflects that.

Current treatment pricing is shown on our treatment page. We don't print per-pen prices in body copy because those numbers shift, and we'd rather you see the live figure alongside exactly what it includes, before you decide.

Why 'cheapest' is the wrong test for a prescription injectable

The MHRA has warned publicly about counterfeit weight-loss pens sold online, including fake tirzepatide pens seized from an illicit manufacturing site in October 2025. Some of those fakes contained the wrong active ingredient entirely. The price signal that should make you pause isn't a provider charging more than average, it's a seller offering these medicines at prices far below the market, without a visible prescription process, through social media or unverified sites.

You can check any online pharmacy in seconds on the GPhC register, that's the right first step before handing over any payment details. Suspect sellers can be reported via the MHRA's Yellow Card scheme.

The Mounjaro price increase is frustrating, especially for patients managing a chronic condition who were settled on a dose. But the response to that frustration that puts you at most risk is searching for the cheapest listing without checking who is behind it. Price is the wrong test for a prescription-only medicine. Supply chain integrity, clinical oversight, and a pharmacy you can verify, those are the right ones. If you want to understand how the price varies by dose, our pages on the 5mg price increase and the 2.5mg starter dose pricing break it down further. And if you're wondering whether some providers held their prices, our guide on providers who didn't increase looks at what that usually means in practice.